Nyxoah SA (NYXH)
NASDAQ
Closed
Oct 9, 2026
Day's Range
1.3552 wk Range
1.26Overview - NYXH - Nyxoah SA
Key Statistics
Valuation
Enterprise Value
117.41M
P/E (Trailing)
‪-0.59‬
P/E (Forward)
‪-1.71‬
PEG Ratio
‪-0.12‬
Price / Sales (TTM)
‪6.67‬
Price / Book
‪1.50‬
EV / EBITDA
‪-1.26‬
Profitability
Gross Margin
‪59.72%‬
Profit Margin
‪63.13%‬
Operating Margin
‪-268.24%‬
Return on Assets
‪-36.86%‬
Return on Equity
‪-122.68%‬
Ownership
Shares Outstanding
100.07M
Float
50.88M
Short % of Shares Outstanding
‪0.30%‬
Held by Insiders
‪33.19%‬
Held by Institutions
‪30.87%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪1.51‬
200-Day Avg
‪2.84‬
Analyst Consensus
4 analysts
Average price target
‪$ 4.38‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NYXH - Nyxoah SA
Peers - NYXH - Nyxoah SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- NYXHNASDAQNyxoah SA144.61MMarket Cap-329.58%52-week change-0.60P/E (Trailing)‪63.13%‬Profit Margin
- ISRGNASDAQIntuitive Surgical Inc.149.77BMarket Cap-2.78%52-week change48.76P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc. Class A Common Stock47.91BMarket Cap-15.14%52-week change44.51P/E (Trailing)‪2.31%‬Profit Margin
- RGENNASDAQRepligen Corporation11.03BMarket Cap+14.50%52-week change238.19P/E (Trailing)‪5.29%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.10.42BMarket Cap+13.90%52-week change25.53P/E (Trailing)‪9.99%‬Profit Margin
- COONASDAQThe Cooper Companies, Inc.10.33BMarket Cap-27.46%52-week change18.53P/E (Trailing)‪13.46%‬Profit Margin
- MMEDNASDAQMiniMed Group, Inc.5.54BMarket Cap+6.19%52-week change-15.17P/E (Trailing)‪-9.74%‬Profit Margin
Profile Summary - NYXH - Nyxoah SA
About
Nyxoah SA is a medical technology company focused on developing and commercializing solutions for obstructive sleep apnea, a common sleep-disordered breathing condition. Nyxoah’s lead product is the Genio system, a patient-centered hypoglossal neurostimulation therapy designed to help treat moderate to severe…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
